发明名称 |
Low acidic species compositions |
摘要 |
The instant invention relates to the field of protein production and purification, and in particular to compositions and processes for controlling the amount of charge variants, aggregates, and fragments of a protein of interest, as well as host cell proteins, present in purified preparations by applying particular chromatography conditions during such protein purification. |
申请公布号 |
US9334319(B2) |
申请公布日期 |
2016.05.10 |
申请号 |
US201313829989 |
申请日期 |
2013.03.14 |
申请人 |
AbbVie Inc. |
发明人 |
Ramasubramanyan Natarajan;Yang Lihua;Herigstad Matthew Omon;Yang Hong;Chumsae Christopher |
分类号 |
C07K16/00;C12P21/08;A61K39/395;C07K16/24;C07K1/16;C07K1/18;C12P21/00;C07K1/20;C07K1/22 |
主分类号 |
C07K16/00 |
代理机构 |
McCarter & English, LLP |
代理人 |
McCarter & English, LLP ;Zacharakis Maria Laccotripe;Tyner Lisa |
主权项 |
1. A composition comprising adalimumab, wherein the composition comprises less than 10% total acidic species of adalimumab, wherein the acidic species of adalimumab correspond to the peaks that elute earlier than the main peak in a WCX-10 HPLC chromatogram of adalimumab, wherein the WCX-10 HPLC chromatogram is generated using a first mobile phase of 10 mM Sodium Phosphate dibasic (pH 7.5) and a second mobile phase of 10 mM Sodium Phosphate dibasic, 500 mM Sodium Chloride (pH 5.5), and wherein the WCX-10 HPLC chromatogram is generated using detection at 280 nm. |
地址 |
North Chicago IL US |